Porous and granular hydroxylapatite (HAP) was implanted in bone defects resulting from oral surgery in 21 patients and from periodontal disease in 14 patients. Excellent results were obtained, the overall clinical usefulness being 91.4%. HAP leakage after implantation was observed in a small number of cases; however, there was almost no wound infection or failure to heal. A series of x-rays confirmed its good adaptation to the bone.
The present communication reports on the use of hydroxylapatite (HAP), which has superior biocompatibility in the oral and maxillary fields; its safety and usefulness were also studied.
Materials and Methods
Materials: We studied 21 patients with bone defects, such as cavities which de veloped after either the removal of jaw bone cysts or after the extraction of impacted teeth; 14 patients with vertical bone resorption were also studied. All of these 35 pa 
Results
All of the cases were designated as either oral surgical or exhibiting periodontal disease, and were then evaluated.
Oral surgical cases: As is shown in Table 1 , "very useful" describes 8 cases (38%), Table 1 Clinical Effect of HAP in the Field of Oral Surgery "fairly useful" describes 12 cases (571% ) , and "no discernible effect" was found in 1 instance (5%); therefore, the overall usefulness was 95%. X-ray and other examinations (Fig. 3) . Under general anesthesia, the impacted tooth was extracted and the cyst removed. The cyst was almost spherical, measuring about 3 cm in diameter. 2.0 grams of HAP was implanted in the bone defect after the re moval. No leakage of HAP was noted after surgery, and the wound healed well.
Orthopantomography, 9 months after surgery, revealed that the margins between the HAP and the surrounding bone were slightly obscured (Fig. 4) cases (36%), "fairly useful" in 7 (50%), and "no effect" in 2 (14%); no adverse effects were evident. The overall usefulness was, therefore, 86%. In the cases showing no effect, almost all of the HAP leaked out because of wound dehiscence after surgery. caine local anesthesia. 0.5 gram of HAP was then implanted in the bone defect around the J area (Fig. 12) . The course after surgery was uneventful, and no leakage of HAP, failure of the wound to heal, nor local or systemic adverse reactions were observed. Fourteen months after surgery, standard dental X-ray revealed that the com bination between the HAP and the bone was very good, since the margin of the neigh boring bone could not be identified. Indeed, a direct bone combination might have occurred, and the HAP, combined with the bone, appeared partially resorbed (Fig. 13) . Improvement was recognized in the periodontal tissue, and a 3 mm attachment gain was obtained; therefore, the results of this case were judged as being "very useful." with tight contact along HAP surface (Fig. 14) . in about one-half of the cases immediately after surgery, but most of these signs dis appeared within a week. This may have been partly due to an excess amount of im planted material. In addition, in cases in which HAP was implanted into a cavity after the extraction of an impacted tooth, the clinical outcome was slightly poorer in those implanted on the palatal surface compared with those implanted on the labial surface. This was most likely because the implanted HAP was too movable; it was, therefore , unable to secure itself sufficiently to acquire adequate stability. In the case of a maxillo-palatal cleft, a cavity formed after the extraction of a tooth near the implant area prevented a complete wound closure. In addition, the HAP -implant was in a difficult position for the HAP to stabilize; therefore, HAP leaked from the suture line and cavity. Also, HAP might not be suitable for children, such as the small, 4 year-old child whose jaw was not well-developed and whose wound closure could not be expected.
Regarding bone resorption due to periodontal disease, HAP was tried in cases of vertical resorption. This was because when HAP was implanted, the relatively stable approximation of the wound might promise new bone formation. However, the 86% usefulness was slightly lower than in cases of oral surgery. This may have been because leakage developed; since the suture was too close to the implanted area the gingival condition prevented a complete wound closure outcome may have been further in fluenced significantly by maintenance treatment, such as brushing. In comparison to conventional surgical procedures in periodontal disease, improved stability and large attachment gain could be easily secured. This was because the HAP implant stayed in the defective area, made a fibrous combination with the neighboring bone, and might have promoted new osteogenesis. There were neither side effects, such as local or systemic allergy reactions caused by HAP, nor any abnormal laboratory data after sur gery. Therefore, the safety of this substance has been demonstrated.
Conclusions
Clinical trials of porous and granular HAP were conducted in a total of 35 sub jects comprising 21 cases of bone defects due to oral surgery and 14 cases of vertical bone defect due to periodontal disease. The following results were obtained: 2. No adverse reactions were noted after HAP implantation, and its safety has been confirmed.
3. Therefore, HAP seems quite useful as a bone substitute for bone defects re sulting from oral surgery and also for vertical bone defects due to periodontal disease.
